Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Jun 10:30:101128.
doi: 10.1016/j.rmcr.2020.101128. eCollection 2020.

Disease recurrence after lung transplantation for idiopathic pulmonary hemosiderosis

Affiliations
Case Reports

Disease recurrence after lung transplantation for idiopathic pulmonary hemosiderosis

Bryan Ross et al. Respir Med Case Rep. .

Abstract

Idiopathic pulmonary hemosiderosis is characterized by the triad of hemoptysis, iron deficiency anemia and pulmonary infiltrates. Though idiopathic pulmonary hemosiderosis has classically been described as a childhood disease, survival into adulthood is possible. Treatment options for advanced and/or refractory disease is limited, and in our unique case of idiopathic pulmonary hemosiderosis with precapillary pulmonary hypertension, lung transplantation has had a favorable short-term outcome. We also demonstrate that disease recurrence of idiopathic pulmonary hemosiderosis following lung transplantation is possible.

Keywords: Disease recurrence; Hemoptysis; Idiopathic pulmonary hemosiderosis; Lung transplant; Pulmonary hypertension.

PubMed Disclaimer

Conflict of interest statement

None.

Figures

Fig. 1
Fig. 1
Pre-transplant computed tomography images showing a dilated pulmonary artery suggestive of pulmonary hypertension (left) and extensive, basal-predominant, centrilobular ground glass opacities with smooth septal thickening (right).
Fig. 2
Fig. 2
Gross (left) and microscopic (right) pathology from explanted native lungs revealing diffuse homogeneous alveolar septal fibrosis with clusters of alveolar hemosiderin-laden macrophages and interstitial hemosiderin deposition.

Similar articles

Cited by

References

    1. Kjellman B., Elinder G., Garwicz S., Svan H. Idiopathic pulmonary haemosiderosis in Swedish children. Acta Paediatr. Scand. 1984;73:584–588. - PubMed
    1. Ohga S., Takahashi K., Miyazaki S., Kato H., Ueda K. Idiopathic pulmonary haemosiderosis in Japan: 39 possible cases from a survey questionnaire. Eur. J. Pediatr. 1995;154:994–995. - PubMed
    1. Taytard J., Nathan N., de Blic J., Fayon M., Epaud R., Deschildre A., Troussier F., Lubrano M., Chiron R., Reix P., Cros P., Mahloul M., Michon D., Clement A., Corvol H. New insights into pediatric idiopathic pulmonary hemosiderosis: the French RespiRare® cohort. Orphanet J. Rare Dis. 2013;8:161–167. - PMC - PubMed
    1. Le Clainche L., Le Bourgeois M., Fauroux B., Forenza N., Dommergues J.P., Desbois J.C., Bellon G., Derelle J., Dutau G., Marguet C., Pin I., Tillie-Leblond I., Scheinmann P., De Blic J. Long-term outcome of idiopathic pulmonary hemosiderosis in children. Medicine. 2000;79:318–326. - PubMed
    1. Saeed M.M., Woo M.S., Mac Laughlin E.F., Margetis M.F., Keens T.G. Prognosis in pediatric idiopathic pulmonary hemosiderosis. Chest. 1999;116:721–725. - PubMed

Publication types

LinkOut - more resources